You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》中金列出內地公募基金上季對港股增幅最多重倉股(表)
中金發表內地公募基金於去年第四季對港股投資趨勢的報告,指2,786隻內地公募基金持有港股市值4,060億人民幣,較去年三季度的3,051億人民幣上升33%,港股持倉佔基金股票總持倉的19.2%,較去年第三季的15.3%提高3.9個百分點,為2021年三季度以來新高。內地公募持股佔南向整體1.97萬億人民幣持倉比例回升2.0個百分點至20.6%。 個股層面,內地公募繼續重倉騰訊(00700.HK)、美團-W(03690.HK)、藥明生物(02269.HK)與快手(01024.HK)等龍頭公司,比亞迪(01211.HK)與中國海外(00688.HK)於去年第四季度取代了華潤啤酒(00291.HK)與青島啤酒(00168.HK)進入了前十大重倉股行列。相比去年第三季度,騰訊、藥明生物與快手等新經濟龍頭持倉市值增幅最大。 中金亦列出內地公募基金於去年第四季對港股增幅最多的部份重倉股預測: 股份│去年末季持股市值(人民幣)│去年末季按季增值市值(人民幣) 騰訊(00700.HK)│454.26億元│241.3億元 藥明生物(02269.HK)│130.14億元│63.1億元 港交所(00388.HK)│118.39億元│55.27億元 快手-W(01024.HK)│109.93億元│54.16億元 金蝶國際(00268.HK)│41.17億元│28.15億元 美團-W(03690.HK)│339.69億元│22.13億元 李寧(02331.HK)│113.28億元│21.75億元 新東方在線(01797.HK)│25.83億元│17.7億元 海吉亞醫療(06078.HK)│28.39億元│15億元 比亞迪(01211.HK)│56.37億元│12.05億元 頤海國際(01579.HK)│12.53億元│11.08億元 九毛九(09922.HK)│18.45億元│9.97億元 華虹半導體(01347.HK)│9.31億元│9.14億元 碧桂園服務(06098.HK)│20.05億元│8.72億元 康成化龍(03759.HK)│11.61億元│8.52億元 友邦(01299.HK)│18.92億元│7.72億元
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account